New Arrivals
Chemical Structure | Cat. No. | Product Name | CAS No. |
---|
BCP21987 | 3-Aminobenzaldehyde New | 1709-44-0 |
BCP21111 | Pretomanid New | 187235-37-6 | |
PA-824 is an experimental anti-tuberculosis drug and one of two nitroimidazoles in phase II clinical trials to treat tuberculosis.
|
BCP43839 | Tafluprost Impurity 21 New | 1563176-58-8 |
BCP09072 | Lificiguat New | 170632-47-0 | |
YC-1(Lificiguat) is a soluble guanylyl cyclase(sGC) activator; binds to the heme-containing domain of the β subunit with Kd value of 0.6-1.1 μM in the presence of CO.
|
BCP28865 | CD1530 New | 107430-66-0 | |
CD-1530 is a retinoic acid receptor γ selective agonist.
|
BCP44295 | Exatecan Intermediate 6 New | 143655-58-7 | |
Exatecan Intermediate 6 is the intermediate of Exatecan(DX-8951) which is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research.
|
BCP00675 | SB202190 New | 152121-30-7 | |
SB 202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinase. SB202190 binds within the ATP pocket of the active kinase (Kd = 38 nM, as measured in recombinant human p38), and selectively inhibits the p38α and β isoforms (IC50 = 50 and 100 nM at SAPK2a/p38 and SAPK2b/p38β2 respectively).
|
BCP49688 | GOAT-IN-1 New | 1452473-54-9 | |
GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT) that may be useful for the prophylaxis or treatment of diabetes, hyperlipidemia, non-alcoholic fatty liver, Alzheimer's disease, Parkinson's disease, cerebrovascular dementia, and cerebral infarction.
|
BCP02612 | Torin 2 New | 1223001-51-1 | |
Torin 2 is potent and selective mTOR inhibitor (IC50 = 2.1 nM).
|
BCP49687 | Ciwujianoside C3 New | 114906-74-0 | |
Ciwujianoside C3 comes from Acanthopanax senticosus.
|
BCP41819 | (R)-Camptothecin New | 110351-92-3 | |
(R)-(-)-Camptothecin is an alkaloid that has been used for the treatment of cancer.
|
BCP29935 | Trisodium UDP glucuronic acid New | 63700-19-6 | |
UDP-D-glucuronide trisodium salt is a crucial compound used for drug metabolism studies.
|
BCP43824 | Bis(1,5-cyclooctadiene)dimethoxydiiridium New | 12148-71-9 |
BCP41126 | SN-001 New | 727699-84-5 | |
SN-001 is a STING inhibitor with an IC50 of 3.82 μM.
|
BCP49686 | Glycochenodeoxycholic acid New | 640-79-9 | |
Glycochenodeoxycholic acid is a bile acid glycine conjugate having 3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl as the bile acid component. It has a role as a human metabolite. It is functionally related to a chenodeoxycholic acid. It is a conjugate acid of a glycochenodeoxycholate.
|
BCP10027 | UDCS New | 128-13-2 | |
Ursodiol reduces cholesterol absorption and is used to dissolve gallstones.
|
BCP49684 | LP-01 New | 1799316-64-5 | |
LP-01 is a cationic lipid useful in the delivery of biologically active agents to cells and tissues.
|
BCP49685 | 3-(4-Bromo-3-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)piperidine-2,6-dione New | 2304754-51-4 |
BCP49676 | 4-(2-Acryloxy-ethyl-1-oxy)-benzoic acidne New | 69260-38-4 |
BCP49677 | (S)-3-Hydroxymethylmorpholine hydrochloride New | 218594-79-7 |